-
1
-
-
47349132331
-
Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: A positive association with combined CYP/GST genotypes
-
Torresan C, Oliveira MM, Torrezan GT, et al. Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin Exp Med 2008; 8: 65-71.
-
(2008)
Clin Exp Med
, vol.8
, pp. 65-71
-
-
Torresan, C.1
Oliveira, M.M.2
Torrezan, G.T.3
-
2
-
-
40449096211
-
Association of CYP1A1 polymorphisms with breast cancer in North Indian women
-
Singh N, Mitra AK, Garg VK, et al. Association of CYP1A1 polymorphisms with breast cancer in North Indian women. Oncol Res. 2007; 16: 587-597.
-
(2007)
Oncol Res
, vol.16
, pp. 587-597
-
-
Singh, N.1
Mitra, A.K.2
Garg, V.K.3
-
3
-
-
3042826342
-
Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women
-
Hefler LA, Tempfer CB, Grimm C, et al. Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer. 2004; 101: 264-269.
-
(2004)
Cancer
, vol.101
, pp. 264-269
-
-
Hefler, L.A.1
Tempfer, C.B.2
Grimm, C.3
-
4
-
-
2942598063
-
Cytochrome P450 gene polymorphism and cancer
-
Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004; 5: 211-224.
-
(2004)
Curr Drug Metab
, vol.5
, pp. 211-224
-
-
Agundez, J.A.1
-
5
-
-
18344381189
-
CYP17 genetic polymorphism in endometrial cancer: Are only steroids involved?
-
Berstein LM, Imyanitov EN, Gamajunova VB, et al. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? Cancer Lett 2002; 180: 47-53.
-
(2002)
Cancer Lett
, vol.180
, pp. 47-53
-
-
Berstein, L.M.1
Imyanitov, E.N.2
Gamajunova, V.B.3
-
6
-
-
41849119124
-
Estrogenbiosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: Results from the Long Island. Breast Cancer Study Project
-
Chen Y, Gammon MD, Teitelbaum SL, et al. Estrogenbiosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island. Breast Cancer Study Project. Carcinogenesis 2008; 29: 766-771.
-
(2008)
Carcinogenesis
, vol.29
, pp. 766-771
-
-
Chen, Y.1
Gammon, M.D.2
Teitelbaum, S.L.3
-
7
-
-
33846616798
-
CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients
-
Chakraborty A, Murthy NS, Chintamani C, et al. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J Hum Genet 2007; 52: 159-165.
-
(2007)
J Hum Genet
, vol.52
, pp. 159-165
-
-
Chakraborty, A.1
Murthy, N.S.2
Chintamani, C.3
-
8
-
-
3042536361
-
Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system
-
Berstein LM, Zimarina TS, Tsyrlina EV, et al. Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system. Vopr Onkol 2004; 50: 169-173.
-
(2004)
Vopr Onkol
, vol.50
, pp. 169-173
-
-
Berstein, L.M.1
Zimarina, T.S.2
Tsyrlina, E.V.3
-
9
-
-
0034691559
-
Breast cancer risk associated with polymorphism in CYP19 in Japanese women
-
Miyoshi Y, Iwao K, Ikeda N, et al. Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer 2000; 89: 325-8
-
(2000)
Int J Cancer
, vol.89
, pp. 325-328
-
-
Miyoshi, Y.1
Iwao, K.2
Ikeda, N.3
-
10
-
-
0032518994
-
Cytochrome P450c17a gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
-
Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17a gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585-587.
-
(1998)
Cancer Res
, vol.58
, pp. 585-587
-
-
Feigelson, H.S.1
Shames, L.S.2
Pike, M.C.3
-
11
-
-
0032475436
-
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
-
Hankinson SE, Wilett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-1299.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1292-1299
-
-
Hankinson, S.E.1
Wilett, W.C.2
Manson, J.E.3
-
12
-
-
0030888153
-
A polymorphism in the CYP17 gene increases the risk of breast cancer
-
Feigelson HS, Coetzee GA, Kolonel LN, et al. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997; 57: 1063-1065.
-
(1997)
Cancer Res
, vol.57
, pp. 1063-1065
-
-
Feigelson, H.S.1
Coetzee, G.A.2
Kolonel, L.N.3
-
13
-
-
0033771003
-
Role of aromatase in sex steroid action
-
Simpson ER. Role of aromatase in sex steroid action. J Mol Endocrinol 2000; 25: 149-156.
-
(2000)
J Mol Endocrinol
, vol.25
, pp. 149-156
-
-
Simpson, E.R.1
-
14
-
-
0032961719
-
Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk
-
Siegelmann-Danieli N, Buetow KH. Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br. J. Cancer 1999; 79: 456-463.
-
(1999)
Br. J. Cancer
, vol.79
, pp. 456-463
-
-
Siegelmann-Danieli, N.1
Buetow, K.H.2
-
15
-
-
0034744673
-
A common promoter variant in the cytochrome P450c17 (CYP17) gene is associated with bioavailable testosterone levels and bone size in men
-
Zmuda J.M, Cauley JA, Kuller LH, et al. A common promoter variant in the cytochrome P450c17 (CYP17) gene is associated with bioavailable testosterone levels and bone size in men. J Bone Miner Res 2001; 16: 911-917.
-
(2001)
J Bone Miner Res
, vol.16
, pp. 911-917
-
-
Zmuda, J.M.1
Cauley, J.A.2
Kuller, L.H.3
-
16
-
-
0029612331
-
Hormones and cancer in humans
-
Key TJ. Hormones and cancer in humans. Mutat Res 1995; 333: 59-67.
-
(1995)
Mutat Res
, vol.333
, pp. 59-67
-
-
Key, T.J.1
-
17
-
-
0032518994
-
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
-
Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585-587.
-
(1998)
Cancer Res
, vol.58
, pp. 585-587
-
-
Feigelson, H.S.1
Shames, L.S.2
Pike, M.C.3
-
18
-
-
0033104346
-
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
-
Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: 1015-1020.
-
(1999)
Cancer Res
, vol.59
, pp. 1015-1020
-
-
Haiman, C.A.1
Hankinson, S.E.2
Spiegelman, D.3
-
19
-
-
0035014268
-
Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'UTR in patients with polycystic ovarian syndrome
-
Marszałek B, Laciński M, Babych N, et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'UTR in patients with polycystic ovarian syndrome. Gynecol. Endocrinol. 2001; 15: 123-128.
-
(2001)
Gynecol. Endocrinol
, vol.15
, pp. 123-128
-
-
Marszałek, B.1
Laciński, M.2
Babych, N.3
-
20
-
-
0033564094
-
CYP17 and breast cancer risk: The polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1
-
Nedelcheva V, Haraldsen EK, Anderson KB, et al. CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1. Cancer Res 1999; 59: 2825-2828.
-
(1999)
Cancer Res
, vol.59
, pp. 2825-2828
-
-
Nedelcheva, V.1
Haraldsen, E.K.2
Anderson, K.B.3
-
21
-
-
0033104346
-
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
-
Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: 1015-1020.
-
(1999)
Cancer Res
, vol.59
, pp. 1015-1020
-
-
Haiman, C.A.1
Hankinson, S.E.2
Spiegelman, D.3
-
22
-
-
2942683102
-
Polymorphisms associated with circulating sex hormone levels in postmenopausal women
-
Dunning AM, Dowsett M, Healey CS, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004; 96: 936-945.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 936-945
-
-
Dunning, A.M.1
Dowsett, M.2
Healey, C.S.3
-
23
-
-
0038059295
-
Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue
-
Miyoshi Y, Ando A, Ooka M, et al. Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue. Cancer Lett 2003; 195: 81-86.
-
(2003)
Cancer Lett
, vol.195
, pp. 81-86
-
-
Miyoshi, Y.1
Ando, A.2
Ooka, M.3
-
24
-
-
0035804638
-
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
-
Jernstrom H, Vesprini D, Bradlow HL, et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2001; 93: 554-555.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 554-555
-
-
Jernstrom, H.1
Vesprini, D.2
Bradlow, H.L.3
-
25
-
-
12344312120
-
Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer
-
Hong C, Thompson H, Jiang C, et al. Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer. Breast Cancer Res Treat 2004; 88: 217-230.
-
(2004)
Breast Cancer Res Treat
, vol.88
, pp. 217-230
-
-
Hong, C.1
Thompson, H.2
Jiang, C.3
-
26
-
-
0032773048
-
Association between CYP17 gene polymorphism and risk of breast cancer in young women
-
Bergman-Jungestrom M, Gentile M, Lundin AC, et al. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int. J. Cancer 1999; 84: 350-353.
-
(1999)
Int. J. Cancer
, vol.84
, pp. 350-353
-
-
Bergman-Jungestrom, M.1
Gentile, M.2
Lundin, A.C.3
-
27
-
-
0034523157
-
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer
-
Mitrunen K, Jourenkova N, Kataja V, et al. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 1343-1348.
-
(2000)
Cancer Epidemiol. Biomarkers Prev
, vol.9
, pp. 1343-1348
-
-
Mitrunen, K.1
Jourenkova, N.2
Kataja, V.3
-
28
-
-
0034684119
-
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
-
Spurdle AB, Hopper JL, Dite GS, et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J. Natl. Cancer Inst 2000; 92: 1674-1681.
-
(2000)
J. Natl. Cancer Inst
, vol.92
, pp. 1674-1681
-
-
Spurdle, A.B.1
Hopper, J.L.2
Dite, G.S.3
-
29
-
-
0036121362
-
The CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis
-
Ye Z, Parry JM. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 2002; 17: 119-126.
-
(2002)
Mutagenesis
, vol.17
, pp. 119-126
-
-
Ye, Z.1
Parry, J.M.2
-
30
-
-
0035112692
-
Polymorphic variation in CYP19 and the risk of breast cancer
-
Baxter SW, Choong DY, Eccles DM, et al. Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 2001; 22: 347-352.
-
(2001)
Carcinogenesis
, vol.22
, pp. 347-352
-
-
Baxter, S.W.1
Choong, D.Y.2
Eccles, D.M.3
-
31
-
-
48749117418
-
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
-
Huang CS, Kuo SH, Lien HC, et al. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. Oncologist 2008; 13: 751-760.
-
(2008)
Oncologist
, vol.13
, pp. 751-760
-
-
Huang, C.S.1
Kuo, S.H.2
Lien, H.C.3
-
32
-
-
4043092284
-
The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese
-
Hirose K, Matsuo K, Toyama T, et al. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese. Cancer Epidemiol. Biomarkers Prev 2004; 13: 1407-1411.
-
(2004)
Cancer Epidemiol. Biomarkers Prev
, vol.13
, pp. 1407-1411
-
-
Hirose, K.1
Matsuo, K.2
Toyama, T.3
|